Safety and antibody response to inactivated COVID‐19 vaccine in patients with chronic hepatitis B virus infection-Reference-Cited by-同舟云学术

Safety and antibody response to inactivated COVID‐19 vaccine in patients with chronic hepatitis B virus infection

Published:2022-02-28 Issue:6 Volume:42 Page:1287-1296
ISSN:1478-3223
Container-title:Liver International
language:en
Short-container-title:Liver International

Author:

He Taiyu¹^ORCID,Zhou Yingzhi¹,Xu Pan¹,Ling Ning¹,Chen Min¹,Huang Tianquan¹,Zhang Biqiong¹,Yang Ziqiao¹,Ao Ling¹,Li Hu¹,Chen Zhiwei¹,Zhang Dazhi¹,Shi Xiaofeng¹,Lei Yu¹,Wang Zhiyi¹,Zeng Weiqun¹,Hu Peng¹^ORCID,Lan Yinghua¹,Zhou Zhi¹,Kang Juan¹,Huang Ying¹,Shi Tongdong¹,Pan Qingbo¹,Zhu Qian¹,Ran Xiping¹,Zhang Yingzhi¹,Song Rui¹,Xiang Dejuan¹,Xiao Shuang¹,Zhang Gaoli¹,Shen Wei¹,Peng Mingli¹,Cai Dachuan¹,Ren Hong¹

Affiliation:

1. Key Laboratory of Molecular Biology for Infectious Diseases (Ministry of Education) Institute for Viral Hepatitis, Department of Infectious Diseases, The Second Affiliated Hospital, Chongqing Medical University Chongqing China

Funder

National Natural Science Foundation of China

National Science and Technology Major Project

Natural Science Foundation of Chongqing

Publisher

Wiley

Subject

Hepatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/liv.15173

Reference25 articles.

1. Clinical characteristics and risk factors of COVID‐19 patients with chronic hepatitis B: a multi‐center retrospective cohort study;Wang J;Front Med,2021

2. Prevalence of chronic liver disease in patients with COVID-19 and their clinical outcomes: a systematic review and meta-analysis

3. Epidemiological and clinical characteristics of 70 cases of coronavirus disease and concomitant hepatitis B virus infection: A multicentre descriptive study

4. Global prevalence, treatment, and prevention of hepatitis B virus infection in 2016: a modelling study

5. Safety and Efficacy of Single-Dose Ad26.COV2.S Vaccine against Covid-19

Cited by 40 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Serological responses to COVID-19 vaccination in patients with chronic liver diseases;Journal of the Formosan Medical Association;2024-06

2. Clinical characteristics and immunogenicity after Omicron breakthrough infection in patients with chronic hepatitis B infection: A longitudinal observational study;Journal of Medical Virology;2024-03

3. Third vaccine boosters and anti‐S‐IgG levels: A comparison of homologous and heterologous responses and poor immunogenicity in hepatocellular carcinoma;The Kaohsiung Journal of Medical Sciences;2024-02-16

4. Investigation of SARS-CoV-2 antibody levels after COVID-19 vaccine in chronic hepatitis B patients;Bratislava Medical Journal;2024

5. Immunogenicity assessment of elder hepatocellular carcinoma patients after inactivated whole-virion SARS-CoV-2 vaccination;Expert Review of Vaccines;2023-11-10